Amgen (AMGN) Finished Goods (2013 - 2017)

Amgen's Finished Goods history runs 5 years deep, the most recent figure standing at $1.1 billion for Q2 2017.

• In Q2 2017, Finished Goods changed N/A year-over-year to $1.1 billion; the TTM figure through Jun 2017 stood at $1.1 billion (changed N/A YoY), while the FY2016 annual figure was $912.0 million, up 29.36% from the prior year.
• Finished Goods was $1.1 billion for Q2 2017 at Amgen, down from $1.2 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.2 billion in Q1 2017 to a low of $705.0 million in Q4 2015.
• Historically, Finished Goods has averaged $920.5 million across 5 years, with a median of $914.0 million in 2014.
• The sharpest annual moves came in 2015 and 2017: Finished Goods slipped 21.49% in 2015, then jumped 48.02% in 2017.
• A 5-year view of Finished Goods shows it stood at $738.0 million in 2013, then advanced by 21.68% to $898.0 million in 2014, then dropped by 21.49% to $705.0 million in 2015, then advanced by 29.36% to $912.0 million in 2016, then rose by 21.27% to $1.1 billion in 2017.
• The last three Finished Goods figures came in at $1.1 billion (Q2 2017), $1.2 billion (Q1 2017), and $912.0 million (Q4 2016), per Business Quant data.